D-1115-2015 Class III Terminated

Recalled by Sandoz, Inc — Princeton, NJ

FDA drug recall D-1115-2015 was initiated by Sandoz, Inc on Apr 15, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point. The recall status is terminated (terminated Oct 5, 2016). Affected quantity: 1,023,430 units.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2015
Initiation Date
Apr 15, 2015
Termination Date
Oct 5, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,023,430 units

Product description

Cetirizine HCl Chewable Tablet, 10 mg, 6-tablets in one blister, in 12 (2 blisters) and 24 (4 blisters) tablet count configurations. Manufactured by Sandoz Private Limited Village-Digham Opp. Thane-Belapur Road Navi Mumbai, 400 078, India, for Sandoz Private Limited 100 College Road West, Princeton, NJ 08540. NDC 66394-041-06

Reason for recall

Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.

Distribution pattern

Nationwide

Code information

Lot #: DP3841, DP5237, DP5238, DP5238A, DP5238B Exp 05/2015; DR7807, DR9954, DR9959, DV5838, Exp 07/2015.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1115-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1115-2015. Report a data issue: hello@regdatalab.com.